NEW YORK (GenomeWeb News) - 454 Life Sciences said on Friday that it has collaborated with the Yale University School of Medicine to use its sequencing technology to identify previously undetectable drug-resistant HIV variants at an early stage.
 
The study authors said that current genotyping technology can only detect resistance mutations at levels of approximately 20 percent or greater, but sequencing is able to detect resistance mutations at the 1 percent level.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.

Jun
12
Sponsored by
Philips Genomics

This webinar will highlight a comprehensive end-to-end solution for precision care in oncology, comprising sample acquisition through to sequencing and analysis, treatment recommendations, and follow-through.

Jun
28
Sponsored by
PerkinElmer

This webinar will review a standardized, high-throughput, and fully automated library prep protocol for human metagenomic analysis.